1
|
Chen X, Liu J, Li Y, Zeng Y, Wang F, Cheng Z, Duan H, Pan G, Yang S, Chen Y, Li Q, Shen X, Li Y, Qin Z, Chen J, Huang Y, Wang X, Lu Y, Shu M, Zhang Y, Wang G, Li K, Lin X, Xing F, Zhang H. IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma. Nat Commun 2023; 14:6781. [PMID: 37880243 PMCID: PMC10600173 DOI: 10.1038/s41467-023-42545-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Accepted: 10/13/2023] [Indexed: 10/27/2023] Open
Abstract
IDH1 mutations frequently occur early in human glioma. While IDH1 mutation has been shown to promote gliomagenesis via DNA and histone methylation, little is known regarding its regulation in antiviral immunity. Here, we discover that IDH1 mutation inhibits virus-induced interferon (IFN) antiviral responses in glioma cells. Mechanistically, D2HG produced by mutant IDH1 enhances the binding of DNMT1 to IRF3/7 promoters such that IRF3/7 are downregulated, leading to impaired type I IFN response in glioma cells, which enhances the susceptibility of gliomas to viral infection. Furthermore, we identify DNMT1 as a potential biomarker predicting which IDH1mut gliomas are most likely to respond to oncolytic virus. Finally, both D2HG and ectopic mutant IDH1 can potentiate the replication and oncolytic efficacy of VSVΔ51 in female mouse models. These findings reveal a pivotal role for IDH1 mutation in regulating antiviral response and demonstrate that IDH1 mutation confers sensitivity to oncolytic virotherapy.
Collapse
Affiliation(s)
- Xueqin Chen
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China
| | - Jun Liu
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Yuqin Li
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Yuequan Zeng
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Fang Wang
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Zexiong Cheng
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Hao Duan
- Department of Neurosurgery/Neuro-oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 510060, Guangzhou, Guangdong, China
| | - Guopeng Pan
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Shangqi Yang
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Yuling Chen
- Department of Pharmacology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, 200032, Shanghai, China
- Ministry of Education (MOE) & Ministry of Health (MOH) Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, 200032, Shanghai, China
| | - Qing Li
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Xi Shen
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Ying Li
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Zixi Qin
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Jiahong Chen
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
- The Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University, 100191, Beijing, China
| | - Youwei Huang
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Xiangyu Wang
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Yuli Lu
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
- Shantou Centre for Disease Control and Prevention, 515000, Shantou, Guangdong, China
| | - Minfeng Shu
- Department of Pharmacology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, 200032, Shanghai, China
- Ministry of Education (MOE) & Ministry of Health (MOH) Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, 200032, Shanghai, China
| | - Yubo Zhang
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Guocai Wang
- Institute of Traditional Chinese Medicine & Natural Products, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, 510632, Guangzhou, Guangdong, China
| | - Kai Li
- Guangdong Research Institute of Gastroenterology, The Sixth Affiliated Hospital of Sun Yat-sen University, 510655, Guangzhou, Guangdong, China
| | - Xi Lin
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China.
| | - Fan Xing
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 510080, Guangzhou, Guangdong, China.
| | - Haipeng Zhang
- Department of Pharmacology, School of Medicine, Jinan University, 510632, Guangzhou, Guangdong, China.
- Key Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan University), Ministry of Education, 510632, Guangzhou, Guangdong, China.
| |
Collapse
|
2
|
Liu G, Zhang X, Zhang X, Hu Y, Li Z, Chen Z, Fu S. Spin-orbit Rabi oscillations in optically synthesized magnetic fields. Light Sci Appl 2023; 12:205. [PMID: 37640695 PMCID: PMC10462765 DOI: 10.1038/s41377-023-01238-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/26/2023] [Revised: 07/05/2023] [Accepted: 07/12/2023] [Indexed: 08/31/2023]
Abstract
Rabi oscillation has been proven to be one of the cornerstones of quantum mechanics, triggering substantial investigations in different disciplines and various important applications both in the classical and quantum regimes. So far, two independent classes of wave states in the Rabi oscillations have been revealed as spin waves and orbital waves, while a Rabi wave state simultaneously merging the spin and orbital angular momentum has remained elusive. Here we report on the experimental and theoretical observation and control of spin-orbit-coupled Rabi oscillations in the higher-order regime of light. We constitute a pseudo spin-1/2 formalism and optically synthesize a magnetization vector through light-crystal interaction. We observe simultaneous oscillations of these ingredients in weak and strong coupling regimes, which are effectively controlled by a beam-dependent synthetic magnetic field. We introduce an electrically tunable platform, allowing fine control of transition between different oscillatory modes, resulting in an emission of orbital-angular-momentum beams with tunable topological structures. Our results constitute a general framework to explore spin-orbit couplings in the higher-order regime, offering routes to manipulating the spin and orbital angular momentum in three and four dimensions. The close analogy with the Pauli equation in quantum mechanics, nonlinear optics, etc., implies that the demonstrated concept can be readily generalized to different disciplines.
Collapse
Affiliation(s)
- Guohua Liu
- Department of Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Guangzhou, 510632, China
| | - Xiliang Zhang
- Department of Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Guangzhou, 510632, China
| | - Xin Zhang
- Department of Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Guangzhou, 510632, China
| | - Yanwen Hu
- Department of Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Guangzhou, 510632, China
| | - Zhen Li
- Department of Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China.
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Guangzhou, 510632, China.
- Guangdong Provincial Engineering Research Center of Crystal and Laser Technology, Guangzhou, 510632, China.
| | - Zhenqiang Chen
- Department of Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Guangzhou, 510632, China
- Guangdong Provincial Engineering Research Center of Crystal and Laser Technology, Guangzhou, 510632, China
| | - Shenhe Fu
- Department of Optoelectronic Engineering, Jinan University, Guangzhou, 510632, China.
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Guangzhou, 510632, China.
- Guangdong Provincial Engineering Research Center of Crystal and Laser Technology, Guangzhou, 510632, China.
| |
Collapse
|